TAN, E.-L., CUMMING, R.B., & HSIE, A.W
Databases such as PubMed, Scopus, and Web of Science were utilized, employing relevant keywords related to the ME/CFS, Gut-Brain Axis, Gut Health, Intestinal Dysbiosis, Microbiome Dysbiosis, Pathophysiology, and Therapeutic Approaches. The goal was to extract qualitative and quantitative data from studies that investigate gut microbiota composition, assess inflammatory markers, and evaluate the therapeutic outcomes of interventions targeting the microbiome
BDNF stacking strategies with other peptides Combining peptides that work through complementary mechanisms is a common approach in research settings
Vitamin B2-is instrumental in reduction of the oxidized form of Glutathione (GSSG) to its reduced form (GSH)
ALA Primarily -linolenic acid DHA Docosahexaenoic acid EPA Eicosatetraenoic acid FAT Fatty acid translocase FATP4 Fatty acid transport protein 4 FFAs Free fatty acids GPx Peroxidase HDL High-density lipoprotein LDL Low-density lipoprotein ROS Reactive oxygen species 2-MAGs 2-Monoacylglycerols 5-MTHF 5-Methyltetrahydrofolate TG Triglycerides TrxR Thioredoxin reductase PUFAs Polyunsaturated fatty acids -3 PUFAs Omega-3 polyunsaturated fatty acids VLDLR Low-density lipoprotein receptor VTG Vitellogenin Fe Iron Cr Chromium I Iodine K Potassium Mn Manganese Na Sodium Se Selenium Zn Zinc Glossary References 1
